-transparent.png){kind=logo}
Saccharomyces cells suffering a single unrepairable double-strand break (DSB) exhibit a long, but transient arrest at G2/M. hdf1 cells, lacking Ku70p, fail to escape from this RAD9/RAD17-dependent checkpoint. The effect of hdf1 results from its accelerated 5' to 3' degradation of the broken chromosome. Permanent arrest in hdf1 cells is suppressed by rad50 or mre11 deletions that retard this degradation. Wild-type HDF1 cells also become permanently arrested when they experience two unrepairable DSBs. Both DSB-induced arrest conditions are suppressed by a mutation in the single-strand binding protein, RPA. We suggest that escape from the DNA damage-induced G2/M checkpoint depends on the extent of ssDNA created at broken chromosome ends. RPA appears to play a key intermediate step in this adaptation.
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
February 2001,
Molecular cell,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
October 2010,
The EMBO journal,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
April 2013,
Proceedings of the National Academy of Sciences of the United States of America,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
August 2023,
International journal of molecular sciences,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
January 1998,
Biochemical and biophysical research communications,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
September 2001,
The Journal of biological chemistry,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
February 2012,
The Journal of biological chemistry,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
September 2010,
Nature,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
May 2001,
Oncogene,
S E Lee, and
J K Moore, and
A Holmes, and
K Umezu, and
R D Kolodner, and
J E Haber
November 2006,
Molecular cancer therapeutics,
